{
    "clinical_study": {
        "@rank": "30057", 
        "arm_group": [
            {
                "arm_group_label": "5% calcium sodium phosphosilicate/ sodium monofluorophosphate", 
                "arm_group_type": "Experimental", 
                "description": "Dentifrice containing 5.0% w/w calcium sodium phosphosilicate and 1500ppmF as sodium monofluorophosphate"
            }, 
            {
                "arm_group_label": "0% calcium sodium phosphosilicate/sodium monofluorophosphate", 
                "arm_group_type": "Active Comparator", 
                "description": "Dentifrice containing 0% w/w calcium sodium phosphosilicate and 1500ppmF as sodium monofluorophosphate"
            }, 
            {
                "arm_group_label": "Sodium monofluorophosphate", 
                "arm_group_type": "Active Comparator", 
                "description": "Dentifrice containing 1000 ppmF as sodium monofluorophosphate"
            }, 
            {
                "arm_group_label": "Sodium fluoride", 
                "arm_group_type": "Active Comparator", 
                "description": "Dentifrice containing 1100 ppmF as sodium fluoride"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this exploratory study is to compare the treatment effect on dentinal\n      hypersensitivity of a tubule occluding dentifrice as measured by Schiff and Tactile\n      sensitivity. This proof of concept study will compare the test dentifrice with three other\n      treatment groups."
        }, 
        "brief_title": "Exploratory Study to Evaluate the Efficacy of an Occlusion Based Dentifrice in Relief of Dentinal Hypersensitivity", 
        "completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "condition": "Dentinal Hypersensitivity", 
        "condition_browse": {
            "mesh_term": "Hypersensitivity"
        }, 
        "detailed_description": {
            "textblock": "This will be a single center, eight week, randomized, controlled, examiner blind, four\n      treatment arms, parallel design study in participants with at least two sensitive teeth that\n      meet all the criteria at the Screening and Baseline visit. Participants will be assessed at\n      baseline, four and eight weeks to monitor clinical efficacy and safety."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Participants between 18 and 55 years of age, in good general health, with\n             pre-existing self-reported and clinically diagnosed tooth sensitivity are required\n             for entry into the study.\n\n          -  Participants will be required to have at least four teeth with facial/cervical\n             erosion, abrasion and/or gingival recession which respond to qualifying evaporative\n             (air) assessment at the Screening visit and have at least two teeth (incisors,\n             canines or pre-molars) demonstrating signs of sensitivity, measured by qualifying\n             tactile threshold (Yeaple \u2264 20 gram (g)) and evaporative (air) (Schiff Sensitivity\n             Score \u2265 2) assessments at the Baseline visit.\n\n        Exclusion Criteria:\n\n          -  Specific Dentition Exclusions for Test teeth\n\n               1. Tooth with evidence of current or recent caries, or reported treatment of decay\n                  in 12 months of Screening.\n\n               2. Tooth with exposed dentin but with deep, defective or facial restorations, teeth\n                  used as abutments for fixed or removable partial dentures, teeth with full\n                  crowns or veneers, orthodontic bands or cracked enamel.  Sensitive teeth with\n                  contributing etiologies other than erosion, abrasion or recession of exposed\n                  dentin.\n\n               3. Sensitive tooth not expected to respond to treatment with an over-the-counter\n                  dentifrice in the opinion of the investigator\n\n          -  Use of a sensitivity dentifrice within 8 weeks of screening\n\n          -  Individuals who require antibiotic prophylaxis for dental procedures"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "55 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "140", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 11, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01831817", 
            "org_study_id": "RH01591"
        }, 
        "intervention": [
            {
                "arm_group_label": "5% calcium sodium phosphosilicate/ sodium monofluorophosphate", 
                "description": "Calcium sodium phosphosilicate dentifrice (5% w/w) and 1500 ppm F as sodium monofluorophosphate", 
                "intervention_name": "5% calcium sodium phosphosilicate/ sodium monofluorophosphate dentifrice", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "0% calcium sodium phosphosilicate/sodium monofluorophosphate", 
                "description": "No calcium sodium phosphosilicate and 1500 ppm F as sodium monofluorophosphate", 
                "intervention_name": "0% calcium sodium phosphosilicate/ sodium monofluorophosphate dentifrice", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Sodium monofluorophosphate", 
                "description": "Sodium monofluorophospate dentifrice (1000 ppm F)", 
                "intervention_name": "Sodium monofluorophosphate dentifrice", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Sodium fluoride", 
                "description": "Dentifrice containing 1100ppm F as sodium fluoride", 
                "intervention_name": "Sodium Fluoride dentifrice", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Calcium, Dietary", 
                "Fluorides", 
                "Sodium Fluoride", 
                "Fluorophosphate", 
                "Listerine"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "July 11, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Fort Wayne", 
                    "country": "United States", 
                    "state": "Indiana", 
                    "zip": "46825"
                }, 
                "name": "Salus Research, Inc."
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "4", 
        "official_title": "A Proof of Concept Study to Evaluate the Efficacy of an Occlusion Based Dentifrice in the Relief of Dentinal Hypersensitivity", 
        "overall_official": {
            "affiliation": "GlaxoSmithKline", 
            "last_name": "GSK Clinical Trials", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Response to a constant jet of air applied to hypersensitive teeth is evaluated using a Schiff Sensitivity pain response scale. According to this analog scale, pain response for each individual stimulated tooth ranged from 0 to 3; 0 - participant does not respond to air stimulation, 1 - participant responds to air stimulus but does not request discontinuation of stimulus, 2 - participant responds to air stimulus and request discontinuation of stimulus, 3 - participant responds to air stimulus, considers stimulus to be painful and request discontinuation of stimulus.", 
                "measure": "Adjusted mean change from baseline in Schiff sensitivity score", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 4 weeks and 8 weeks post administration of study treatment"
            }, 
            {
                "description": "Response to increasing force on hypersensitive teeth is evaluated using a Yeaple Probe pain response scale. According to this tactile sensitivity assessment, an increasing force is applied to hypersensitive tooth until a yes response is recorded or the maximum force has been reached.", 
                "measure": "Adjusted mean change from baseline in tactile sensitivity pain response", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 4 weeks and 8 weeks post administration of study treatment"
            }, 
            {
                "description": "Participants will rate the intensity of their response to the stimulus using a 10 point Visual rating scale of 1 (no Pain) to 10 (intense pain).", 
                "measure": "Adjusted mean change from baseline in evaporative air sensitivity response on a Visual Rating Scale", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 4 weeks and 8 weeks post administration of study treatment"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01831817"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "GlaxoSmithKline", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "GlaxoSmithKline", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}